Dividends Calendar Earnings Calendar
HALO

HALO | Halozyme Therapeutics Inc

45.98 -1.59 (-3.34%) 
Healthcare sector
Halozyme Therapeutics Inc

Company profile

  • Industry: Biotechnology
  • Sector: Healthcare
  • Headquarters:   San Diego, California, United States
  • Number of employees::   288
Investor Relations : www.halozyme.com

About the Company

Halozyme Therapeutics is a U.S. biotechnology company that develops novel oncology therapies designed to target the tumor microenvironment and licenses a novel drug delivery technology through corporate partnerships. The company was founded in 1998 and went public in 2004.

  • Subsidiaries:   Subsidiary: Halozyme, Inc.
  • Revenue: 288 million USD (2019)

    Key Persons / Board of Directors

    • CEO :  Helen I. Torley (6 Jan 2014–)


    Jump to (Finance sites)

    Google     
             

    Research 


    Investor page

    www.halozyme.com

    If you are looking for News & events, Press Release, they are available on their Investors Relationssite.


    Consensus
    BUY 80
    HOLD 20
    SELL 0

    Their Official Profiles 

    WikipediaTwitterLinkedInYoutube

    Support this project

    If you want to help pay for server cost or for improving this tool. You can send it via Paypal.
    More features coming soon :)

    Social Media 




    Recommended Books

    The Intelligent Investor
    Buy on Amazon

    Graham's philosophy of "value investing" has made The Intelligent Investor the stock market bible ever since its original publication in 1949.

    The best book on investing ever written.
    -- Warren Buffet